+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Menopause Market by Product Type (Hormone Replacement Therapy (HRT), Non-Hormonal Treatments), Stage of Menopause (Menopause, Perimenopause, Postmenopause), Route of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Menopause Market by Product Type (Hormone Replacement Therapy (HRT), Non-Hormonal Treatments), Stage of Menopause (Menopause, Perimenopause, Postmenopause), Route of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Menopause Market by Product Type (Hormone Replacement Therapy (HRT), Non-Hormonal Treatments), Stage of Menopause (Menopause, Perimenopause, Postmenopause), Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454968
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Menopause Market grew from USD 19.97 billion in 2024 to USD 21.39 billion in 2025. It is expected to continue growing at a CAGR of 7.32%, reaching USD 30.52 billion by 2030.

Menopause has emerged as a focal point in contemporary healthcare, not only due to its biological complexities but also because of the evolving treatment paradigms that are reshaping patient care. Over the past few years, significant research and clinical data have driven improvements in both therapeutic options and patient outcomes. In recent times, medical professionals and industry leaders alike have observed a transformative period wherein innovation meets an increasing demand for personalized treatment protocols.

This shift is anchored in the recognition of menopause as a multifaceted condition - one that intersects with lifestyle, economic factors, and regional healthcare trends. Consequently, decision-makers now have an enriched understanding of the market driven by rigorous segmentation and regional analytics. The refined focus on tailoring approaches for various patient segments has spurred an adoption of both advanced hormone replacement modalities and a range of non-hormonal alternatives. The introduction sets the stage by discussing the significance of these shifts while also shedding light on the underlying market imperatives that will be explored in-depth in the following sections.

The journey ahead delves into detailed explorations of therapeutic categories, stage-specific treatment approaches, methods of drug administration, and the influence of various distribution channels, all underscored by emerging industry trends and robust data analytics.

Transformative Shifts in the Menopause Treatment Landscape

Recent years have witnessed a paradigm shift in the approach to menopause treatment that extends far beyond the conventional methods. This evolving narrative is driven by continuous innovation and an increased understanding of patient needs. Critics and supporters alike recognize that modern medicine is embracing a diversified range of therapies that ensure patient-focused outcomes. Scientific research has particularly underscored the importance of a comprehensive offering - where hormonal and non-hormonal treatment avenues coexist as viable and complementary options.

The market has been methodically segmented by product type, considering traditional Hormone Replacement Therapy (HRT) as well as Non-Hormonal Treatments. Within HRT, further distinctions such as Combined Estrogen-Progesterone Therapy, Estrogen Therapy, and Progesterone Therapy set the tone for personalized interventions. Non-Hormonal Treatments, on the other hand, are gaining attention as candidates like antidepressants, botanical supplements, gabapentin, and pregabalin demonstrate potential, with in-depth studies on sub-categories like Citalopram, Escitalopram, and Fluoxetine offering fresh perspectives on efficacy.

Alongside treatment modality advancements, shifting patient demographics and regional health dynamics catalyze these transformative changes, urging industry professionals to adopt strategies that are both innovative and sensitive to the nuances of varied therapeutic needs.

Key Segmentation Insights Driving Market Dynamics

Insights derived from meticulous segmentation analysis reveal that a stratified approach to the market is central to understanding the evolving dynamics of menopause treatments. Analysts segment the product spectrum into two primary categories: Hormone Replacement Therapy and Non-Hormonal Treatments. Within the HRT segment, the further breakdown into Combined Estrogen-Progesterone Therapy, Estrogen Therapy, and Progesterone Therapy illustrates a commitment to addressing diverse hormonal profiles and individualized treatment regimens. In contrast, the Non-Hormonal Treatments category encompasses alternatives such as antidepressants, botanical supplements, gabapentin, and pregabalin, with a specific focus on variants like Citalopram, Escitalopram, and Fluoxetine, each offering unique benefits depending on patient symptoms and risk profiles.

Furthermore, market strategies extend to stage-based segmentation, which dissects the menopausal journey into Menopause, Perimenopause, and Postmenopause. This critical division ensures that treatments are appropriately timed and aligned with the physiological changes inherent to each stage, thereby bolstering therapeutic outcomes. Additionally, the analysis embraces operational dimensions such as the route of administration - covering enteral, parenteral, and topical approaches - and the distribution networks that include hospital pharmacies, online portals via company websites and eCommerce platforms, as well as traditional retail pharmacies. Together, these segmentations provide a robust framework that informs strategic decision-making and supports the design of targeted interventions across the care continuum.

Based on Product Type, market is studied across Hormone Replacement Therapy (HRT) and Non-Hormonal Treatments. The Hormone Replacement Therapy (HRT) is further studied across Combined Estrogen-Progesterone Therapy, Estrogen Therapy, and Progesterone Therapy. The Non-Hormonal Treatments is further studied across Antidepressants, Botanical Supplements, Gabapentin, and Pregabalin. The Antidepressants is further studied across Citalopram, Escitalopram, and Fluoxetine.

Based on Stage of Menopause, market is studied across Menopause, Perimenopause, and Postmenopause.

Based on Route of Administration, market is studied across Enteral, Parenteral, and Topical.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Online Pharmacies is further studied across Company Websites and eCommerce Platforms.

Key Regional Insights Shaping the Menopause Market

Regional analysis offers invaluable insights into the market’s geographic variations, essentially highlighting how socioeconomic factors and regional healthcare infrastructures influence patient access to treatment. In the Americas, healthcare policies and insurance paradigms create an enabling environment for both emerging and established treatment modalities, promoting a dynamic landscape that supports innovation. The region observes a robust integration of the latest therapeutic practices, supported by significant investments in research and technology.

In Europe, the Middle East, and Africa, a blend of traditional healthcare practices meets modern medical advancements. This region is characterized by its diverse regulatory frameworks and a unique set of challenges pertaining to healthcare affordability, cultural acceptance, and accessibility of medical innovations. Market strategies are being continuously refined to bridge the gap between advanced treatments and local patient needs.

The Asia-Pacific region presents a particularly vibrant and competitive market where rapid urbanization, a growing middle class, and increased awareness of health issues drive demand. Here, patient preference leans towards highly accessible and cost-effective solutions, making the region a fertile ground for both innovative treatments and comprehensive awareness campaigns. Collectively, these regional observations lay the groundwork for understanding the broader market trends and highlight the strategic opportunities available within each territory.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Influencing the Menopause Market Landscape

The market ecosystem is further enriched by the significant contributions of key companies that are steering innovation and shaping competitive dynamics across the menopause treatment landscape. Industry leaders such as Abbott Laboratories, Abbvie Inc., Amgen Inc., and Apotex Inc. have played pivotal roles in advancing both hormonal and non-hormonal treatment benchmarks. Their research and technological investments have paved the way for groundbreaking clinical solutions. Moreover, notable contributions from Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, and Cipla Ltd. ensure that advancements are not confined to just one segment but span across multiple therapeutic avenues.

Adding to the competitive tapestry are Eli Lilly and Company, Ferring International Center S.A., Fervent Pharmaceuticals, LLC, and Gedeon Richter PLC, each of whom leverages decades of clinical expertise and research acumen to support patient-centric innovations. Industry giants like GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Ipsen Group, and Merck & Co. Inc. have consistently influenced market evolution through strategic collaborations and robust R&D endeavors. Further reinforcing the landscape are Mithra Pharmaceuticals S.A., Novartis AG, Novo Nordisk A/S, Organon & Co, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., TherapeuticsMD Inc., and Viatris Inc. Their integration of cutting-edge research with commercial strategies is not only driving product development but also fostering an environment where market feedback and clinical insights lead to continual innovation.

These leading companies collectively exemplify a commitment to excellence and a proactive approach to addressing the multifaceted challenges associated with menopause management, setting standards that other market participants aspire to match.

The report delves into recent significant developments in the Menopause Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abbvie Inc., Amgen Inc., Apotex Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Cipla Ltd., Eli Lilly and Company, Ferring International Center S.A., Fervent Pharmaceuticals, LLC, Gedeon Richter PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Ipsen Group, Merck & Co.Inc., Mithra Pharmaceuticals S.A., Novartis AG, Novo Nordisk A/S, Organon & Co, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., TherapeuticsMD Inc., and Viatris Inc..

Actionable Recommendations for Strategic Leadership in Menopause Treatments

Given the fast-evolving landscape in menopause treatments, industry leaders are encouraged to embrace an innovation-centric strategy that merges clinical insights with market trends. Leaders should intensify their focus on data-driven decision making to better understand patient demographics and regional market needs. Investments in research and technology are critical to ensuring that both hormonal and non-hormonal treatment options remain robust and adaptable to emerging trends.

Organizations should prioritize developing personalized treatment protocols that integrate an understanding of the menopausal stages along with the most effective treatment modalities, whether through advanced hormone replacement therapies or viable non-hormonal interventions. Exploring strategic collaborations with key research institutions and healthcare providers can also create synergies that drive patient engagement and improve outcomes.

Furthermore, a strong emphasis on digital transformation, particularly in expanding and refining online distribution channels, will help improve access to innovative treatments. Embracing modern digital solutions such as telemedicine and eCommerce platforms not only enhances patient outreach but also streamlines operational efficiencies. Ultimately, by aligning strategic investments with the evolving needs of patients and leveraging key insights from market segmentation and regional dynamics, leaders can secure a competitive edge while ensuring long-term sustainable growth.

Synthesizing Insights for a Progressive Future

Concluding this comprehensive analysis, the menopause treatment landscape is clearly marked by significant transformations, driven by innovations in both therapeutic modalities and market strategies. The nuanced segmentation - ranging from product type and treatment modality to stage-specific approaches - provides a multifaceted understanding of the market. These insights are enriched by regional and company-specific perspectives, with key markets such as the Americas, Europe, the Middle East, Africa, and the Asia-Pacific showcasing unique yet interconnected trends.

This evolving narrative underscores the imperative for industry stakeholders to adopt a flexible yet forward-thinking approach. The integration of cutting-edge research with personalized patient care is transforming the management of menopause into a truly patient-centric model. As new data emerge and technology continues to reshape healthcare delivery, leaders are poised to capitalize on emerging opportunities while addressing the pertinent challenges head-on.

In essence, the journey towards enhancing menopause treatment is not just about clinical innovations; it is also about strategically navigating market dynamics, fostering regional cooperation, and building collaborative ecosystems that benefit all stakeholders. The synthesis of these insights ultimately heralds a future marked by improved care outcomes and a more resilient healthcare system.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness and diagnosis of menopause symptoms driving demand for specialized care
5.1.1.2. Rising aging population and extended female lifespan contributing to a larger market for menopausal products
5.1.1.3. Growing prevalence of early onset menopause and perimenopause conditions affecting a wider demographic
5.1.2. Restraints
5.1.2.1. High costs associated with R&D and clinical trials in developing menopause solutions
5.1.3. Opportunities
5.1.3.1. Development of comprehensive telemedicine solutions to provide personalized menopause health assessments and remote guidance
5.1.3.2. Innovative wearable health monitoring devices that track hormonal changes and menopause symptoms with real-time analysis
5.1.4. Challenges
5.1.4.1. Regulatory and compliance hurdles within the menopause healthcare industry
5.2. Market Segmentation Analysis
5.2.1. Product Type: Growing adoption of non-hormonal treatments due to increasing consumer interest in natural wellness alternatives
5.2.2. Distribution Channel: Rising consumer preference for hospital pharmacies ensuring clinical oversight and prescription accuracy
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Menopause Market, by Product Type
6.1. Introduction
6.2. Hormone Replacement Therapy (HRT)
6.2.1. Combined Estrogen-Progesterone Therapy
6.2.2. Estrogen Therapy
6.2.3. Progesterone Therapy
6.3. Non-Hormonal Treatments
6.3.1. Antidepressants
6.3.1.1. Citalopram
6.3.1.2. Escitalopram
6.3.1.3. Fluoxetine
6.3.2. Botanical Supplements
6.3.3. Gabapentin
6.3.4. Pregabalin
7. Menopause Market, by Stage of Menopause
7.1. Introduction
7.2. Menopause
7.3. Perimenopause
7.4. Postmenopause
8. Menopause Market, by Route of Administration
8.1. Introduction
8.2. Enteral
8.3. Parenteral
8.4. Topical
9. Menopause Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.3.1. Company Websites
9.3.2. eCommerce Platforms
9.4. Retail Pharmacies
10. Americas Menopause Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Menopause Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Menopause Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. Coral secures CAD 4.1 million seed funding led by Brightspark to launch an integrated digital platform
13.3.2. Carrot Fertility’s virtual menopause and midlife clinic harnesses telemedicine for hormone therapy
13.3.3. Emcure Pharmaceuticals unveils Arth lineup to support women's health during menopause with affordable solutions
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. MENOPAUSE MARKET MULTI-CURRENCY
FIGURE 2. MENOPAUSE MARKET MULTI-LANGUAGE
FIGURE 3. MENOPAUSE MARKET RESEARCH PROCESS
FIGURE 4. MENOPAUSE MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 15. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MENOPAUSE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MENOPAUSE MARKET DYNAMICS
TABLE 7. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINED ESTROGEN-PROGESTERONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTERONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MENOPAUSE MARKET SIZE, BY CITALOPRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MENOPAUSE MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MENOPAUSE MARKET SIZE, BY FLUOXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MENOPAUSE MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MENOPAUSE MARKET SIZE, BY GABAPENTIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MENOPAUSE MARKET SIZE, BY PREGABALIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MENOPAUSE MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MENOPAUSE MARKET SIZE, BY PERIMENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MENOPAUSE MARKET SIZE, BY POSTMENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MENOPAUSE MARKET SIZE, BY ENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MENOPAUSE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MENOPAUSE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MENOPAUSE MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MENOPAUSE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 40. AMERICAS MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 57. BRAZIL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 63. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 65. CANADA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 66. CANADA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 67. CANADA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 68. CANADA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. CANADA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 73. MEXICO MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. MEXICO MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. CHINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. CHINA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 107. CHINA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 108. CHINA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 109. CHINA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 110. CHINA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. CHINA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 113. INDIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. INDIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 115. INDIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 116. INDIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 117. INDIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 118. INDIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. INDIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. INDIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 123. INDONESIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 129. JAPAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. JAPAN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 131. JAPAN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 132. JAPAN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 133. JAPAN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 134. JAPAN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. JAPAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. JAPAN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 171. TAIWAN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177. THAILAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. THAILAND MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 179. THAILAND MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 180. THAILAND MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 181. THAILAND MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 182. THAILAND MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. THAILAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. THAILAND MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 187. VIETNAM MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 202. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. DENMARK MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 204. DENMARK MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. DENMARK MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 210. EGYPT MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. EGYPT MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 212. EGYPT MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 213. EGYPT MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 214. EGYPT MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. EGYPT MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 218. FINLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 220. FINLAND MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 221. FINLAND MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. FINLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. FINLAND MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. FRANCE MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 228. FRANCE MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 229. FRANCE MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 231. FRANCE MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. FRANCE MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 234. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. GERMANY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 236. GERMANY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 237. GERMANY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 238. GERMANY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 239. GERMANY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. GERMANY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 244. ISRAEL MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 250. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. ITALY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 252. ITALY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 253. ITALY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 254. ITALY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 255. ITALY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. ITALY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 268. NIGERIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 274. NORWAY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. NORWAY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 276. NORWAY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 277. NORWAY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 278. NORWAY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 279. NORWAY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. NORWAY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. NORWAY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 282. POLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. POLAND MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 284. POLAND MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 285. POLAND MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 286. POLAND MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 287. POLAND MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 288. POLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. POLAND MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 290. QATAR MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. QATAR MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 292. QATAR MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 293. QATAR MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 294. QATAR MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 295. QATAR MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. QATAR MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. QATAR MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 300. RUSSIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 322. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. SPAIN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 324. SPAIN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 325. SPAIN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 326. SPAIN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 327. SPAIN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 328. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 329. SPAIN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 332. SWEDEN MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 338. SWITZERLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. SWITZERLAND MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 346. TURKEY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 347. TURKEY MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 348. TURKEY MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 349. TURKEY MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 350. TURKEY MENOPAUSE MARKET SIZE, BY STAGE OF MENOPAUSE, 2018-2030 (USD MILLION)
TABLE 351. TURKEY MENOPAUSE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 352. TURKEY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 353. TURKEY MENOPAUSE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONE REPLACEMENT THERAPY (HRT), 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY NON-HORMONAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 358. UNIT

Companies Mentioned

  • Abbott Laboratories
  • Abbvie Inc.
  • Amgen Inc.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Cipla Ltd.
  • Eli Lilly and Company
  • Ferring International Center S.A.
  • Fervent Pharmaceuticals, LLC
  • Gedeon Richter PLC
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Ipsen Group
  • Merck & Co.Inc.
  • Mithra Pharmaceuticals S.A.
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 21.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 30.52 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Hormone Replacement Therapy Market Outlook, 2029 - Product Image

Hormone Replacement Therapy Market Outlook, 2029

  • Report
  • 192 Pages
  • Global
From
Hormone Replacement Therapy Market Overview, 2024-2029 - Product Image

Hormone Replacement Therapy Market Overview, 2024-2029

  • Report
  • 105 Pages
  • Global
From
Hormone Replacement Therapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Hormone Replacement Therapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 135 Pages
  • Global
From
Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033 - Product Image

Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From

About the Market

The Menopause market is a subset of the Women's Health industry, focusing on the physical and emotional changes experienced by women during the transition from reproductive to non-reproductive years. It includes products and services that help women manage the symptoms of menopause, such as hot flashes, night sweats, mood swings, and vaginal dryness. It also includes treatments for conditions associated with menopause, such as osteoporosis, heart disease, and urinary incontinence. The Menopause market is a growing industry, with an increasing number of products and services available to women. Companies in the market include pharmaceutical companies, health care providers, and wellness companies. Examples include Hormone Health Network, Menopause Solutions, and Menopause Support. Additionally, there are a number of online resources and support groups available to women going through menopause. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.